Old Web
English
Sign In
Acemap
>
Paper
>
FDA-approved Pralatrexate identified by virtual drug screening inhibits SARS-CoV-2 replication in vitro
FDA-approved Pralatrexate identified by virtual drug screening inhibits SARS-CoV-2 replication in vitro
2020
Haiping Zhang
Yang Yang
Junxin Li
Min Wang
Konda Mani Saravanan
Jinli Wei
Justin Tze Yang Ng
Md. Tofazzal. Hossain
Maoxuan Liu
Huiling Zhang
Xiaohu Ren
Yi Pan
Yin Peng
Yi Shi
Xiaochun Wan
Yingxia Liu
Yanjie Wei
Keywords:
In vitro
severe acute respiratory syndrome coronavirus 2
Virology
Pralatrexate
Drug
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]